|
Mr. Kirk has over 20 years of experience in the health care industry. Mr. Kirk founded and became Chairman of the Board of New River Pharmaceuticals Inc. (previously traded on NASDAQ prior to its acquisition by Shire plc in 2007) in 1996 which was a specialty pharmaceutical company focused on developing novel pharmaceuticals and improved versions of widely-prescribed drugs and was President and Chief Executive Officer between October 2001 and April 2007. Previously Mr. Kirk co-founded General Injectables & Vaccines Inc. (GIV) a pharmaceutical distributor in 1983 and served as Chairman of the board of GIV prior to the sale of that company in 1998. Mr. Kirk served as a member of the board of directors of Scios Inc. (previously traded on Nasdaq and acquired by Johnson & Johnson for $2.4 billion) between February 2000 and May 2002. Mr. Kirk also currently serves as Senior Managing Director of Third Security LLC an investment management firm founded by Mr. Kirk. In addition he has served as a member of the board of directors of Clinical Data Inc. (Nasdaq: CLDA) since September 2002 and as chairman of its board since December 2004. He has served on the board of directors of the Radford University Foundation Inc. since September 1998 the Virginia Bioinformatics Institute Policy Advisory Board since March 2004 and the Board of Visitors of Radford University since July 2003. He serves on a number of other foundations as well. Mr. Kirk received his B.A. in Business from Radford University and his J.D. from the University of Virginia. Mr. Kirk serves on the Nominating and Governance Committee. | 